Barotrauma Clinical Trial
Official title:
Pseudoephedrine Prophylaxis for Prevention of Middle Ear Barotrauma in Hyperbaric Oxygen Therapy
The purpose of this research is to study whether the use of pseudoephedrine can help prevent middle ear trauma during HBOT. Pseudoephedrine is an approved drug that is used for temporary relief of nasal or sinus pain and pressure.
Subjects will be asked to take a pill (pseudoephedrine or placebo) between 45 and 120 minutes before hyperbaric oxygen therapy. Subjects' ears will be examined before and after therapy and be asked to assess ear pain. There will be no further tests or procedures after completion of therapy session and ear examinations. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04435327 -
Lung Damage Caused by SARS-CoV-2 Pneumonia (COVID-19)
|
||
| Completed |
NCT03242057 -
Comparison of Primary Extubation Failure Between NIPPV and NI-NAVA
|
N/A | |
| Recruiting |
NCT06001645 -
Laboratory Biomarkers and Pulmonary Interstitial Emphysema in ARDS (PIE-ARDS)
|
||
| Completed |
NCT05877443 -
Barotrauma in Adults With Critical COVID-19
|
||
| Completed |
NCT05216523 -
"Barotrauma in Admitted Covid-19 Cases - A Single Center Retrospective Study"
|
||
| Withdrawn |
NCT01384500 -
The Ornge Comparison of Tracheal Occlusion Pressures to Ensure Safety Trial
|
N/A | |
| Enrolling by invitation |
NCT04726306 -
Diagnostic Precision and Accuracy Using the Teed Scoring System Versus the O'Neill Grading System
|
||
| Recruiting |
NCT05816954 -
Imaging Biomarkers to Stratify the Risk of Barotrauma in ARDS
|
||
| Completed |
NCT04859881 -
Risk Factors for Barotrauma in COVID-19
|